Published in J Biol Chem on November 09, 2009
Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today (2013) 1.28
Blockade of neuronal α7-nAChR by α-conotoxin ImI explained by computational scanning and energy calculations. PLoS Comput Biol (2011) 0.96
Synthetic α-conotoxin mutants as probes for studying nicotinic acetylcholine receptors and in the development of novel drug leads. Toxins (Basel) (2010) 0.85
A novel approach for in vivo screening of toxins using the Drosophila Giant Fiber circuit. Toxicon (2010) 0.82
Natural compounds interacting with nicotinic acetylcholine receptors: from low-molecular weight ones to peptides and proteins. Toxins (Basel) (2015) 0.80
Discovery of a potent and selective α3β4 nicotinic acetylcholine receptor antagonist from an α-conotoxin synthetic combinatorial library. J Med Chem (2014) 0.79
Integrating computational and mixture-based screening of combinatorial libraries. J Mol Model (2010) 0.79
Crystallography & NMR system: A new software suite for macromolecular structure determination. Acta Crystallogr D Biol Crystallogr (1998) 169.28
VMD: visual molecular dynamics. J Mol Graph (1996) 117.02
Scalable molecular dynamics with NAMD. J Comput Chem (2005) 59.49
MOLMOL: a program for display and analysis of macromolecular structures. J Mol Graph (1996) 39.73
Multiple sequence alignment with the Clustal series of programs. Nucleic Acids Res (2003) 38.75
AQUA and PROCHECK-NMR: programs for checking the quality of protein structures solved by NMR. J Biomol NMR (1996) 29.55
Torsion angle dynamics for NMR structure calculation with the new program DYANA. J Mol Biol (1997) 15.40
General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. Proc Natl Acad Sci U S A (1985) 8.77
PROMOTIF--a program to identify and analyze structural motifs in proteins. Protein Sci (1996) 6.76
In situ neutralization in Boc-chemistry solid phase peptide synthesis. Rapid, high yield assembly of difficult sequences. Int J Pept Protein Res (1993) 5.82
Structures of Aplysia AChBP complexes with nicotinic agonists and antagonists reveal distinctive binding interfaces and conformations. EMBO J (2005) 5.55
Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annu Rev Pharmacol Toxicol (2007) 5.48
A hierarchical approach to all-atom protein loop prediction. Proteins (2004) 5.18
Nicotinic receptors: allosteric transitions and therapeutic targets in the nervous system. Nat Rev Drug Discov (2009) 3.26
Neuronal nicotinic acetylcholine receptors: structural revelations, target identifications, and therapeutic inspirations. J Med Chem (2005) 2.94
Crystal structure of nicotinic acetylcholine receptor homolog AChBP in complex with an alpha-conotoxin PnIA variant. Nat Struct Mol Biol (2005) 2.45
Rapid identification of high affinity peptide ligands using positional scanning synthetic peptide combinatorial libraries. Biotechniques (1992) 1.89
Structural determinants of selective alpha-conotoxin binding to a nicotinic acetylcholine receptor homolog AChBP. Proc Natl Acad Sci U S A (2006) 1.78
Mixture-based synthetic combinatorial libraries. J Med Chem (1999) 1.74
Were arachnids the first to use combinatorial peptide libraries? Peptides (2005) 1.55
Rat alpha3/beta4 subtype of neuronal nicotinic acetylcholine receptor stably expressed in a transfected cell line: pharmacology of ligand binding and function. Mol Pharmacol (1998) 1.52
Conus venoms - a rich source of peptide-based therapeutics. Curr Pharm Des (2008) 1.48
The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands. Life Sci (1993) 1.36
AChBP-targeted alpha-conotoxin correlates distinct binding orientations with nAChR subtype selectivity. EMBO J (2007) 1.35
The synthesis, structural characterization, and receptor specificity of the alpha-conotoxin Vc1.1. J Biol Chem (2006) 1.28
Peptide libraries: determination of relative reaction rates of protected amino acids in competitive couplings. Biopolymers (1994) 1.28
Alpha-conotoxins as pharmacological probes of nicotinic acetylcholine receptors. Acta Pharmacol Sin (2009) 1.22
A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes. Mol Immunol (2004) 1.15
Folding of conotoxins: formation of the native disulfide bridges during chemical synthesis and biosynthesis of Conus peptides. Antioxid Redox Signal (2008) 1.12
Structural elements in alpha-conotoxin ImI essential for binding to neuronal alpha7 receptors. J Biol Chem (1998) 1.10
Functional characterization of mouse alpha4beta2 nicotinic acetylcholine receptors stably expressed in HEK293T cells. J Neurochem (2004) 1.10
NMR solution structure of alpha-conotoxin ImI and comparison to other conotoxins specific for neuronal nicotinic acetylcholine receptors. Biochemistry (1999) 1.04
Conotoxins as research tools and drug leads. Curr Protein Pept Sci (2005) 1.02
Amino acid residues that confer high selectivity of the alpha6 nicotinic acetylcholine receptor subunit to alpha-conotoxin MII[S4A,E11A,L15A]. J Biol Chem (2008) 0.99
Solution structure of alpha-conotoxin ImI by 1H nuclear magnetic resonance. J Med Chem (1999) 0.98
Selective ligands for the mu, delta, and kappa opioid receptors identified from a single mixture based tetrapeptide positional scanning combinatorial library. J Biol Chem (1998) 0.98
Combinatorial peptide libraries as an alternative approach to the identification of ligands for tumor-reactive cytolytic T lymphocytes. Cancer Res (2001) 0.96
Alpha-conotoxins PnIA and [A10L]PnIA stabilize different states of the alpha7-L247T nicotinic acetylcholine receptor. J Biol Chem (2003) 0.95
Hyperhydroxylation: a new strategy for neuronal targeting by venomous marine molluscs. Prog Mol Subcell Biol (2006) 0.94
Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor. J Biol Chem (2009) 0.94
A new level of conotoxin diversity, a non-native disulfide bond connectivity in alpha-conotoxin AuIB reduces structural definition but increases biological activity. J Biol Chem (2002) 0.92
Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analogues. J Biol Chem (2008) 0.89
Coupling of human nicotinic acetylcholine receptors alpha 7 to calcium channels in GH3 cells. Neuropharmacology (2004) 0.88
Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives. J Biol Chem (2009) 0.87
Structure-activity relationships in a peptidic alpha7 nicotinic acetylcholine receptor antagonist. J Mol Biol (2000) 0.83
Alpha4/3 conotoxins: phylogenetic distribution, functional properties, and structure-function insights. Chem Rec (2007) 0.82
Pharmacological characteristics and binding modes of caracurine V analogues and related compounds at the neuronal alpha7 nicotinic acetylcholine receptor. J Med Chem (2007) 0.81
High-throughput synthesis of conopeptides: a safety-catch linker approach enabling disulfide formation in 96-well format. J Pept Sci (2007) 0.81
Aromatic substitutions in alpha-conotoxin ImI. Synthesis of iodinated photoactivatable derivative. Toxicon (1999) 0.80
Cosolvent-assisted oxidative folding of a bicyclic alpha-conotoxin ImI. J Pept Sci (2004) 0.79
Combinatorial synthesis of omega-conotoxin MVIIC analogues and their binding with N- and P/Q-type calcium channels. FEBS Lett (2000) 0.76
Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity. Cancer Cell (2004) 3.14
Specificity and degeneracy of T cells. Mol Immunol (2004) 1.71
Microcin J25 has a threaded sidechain-to-backbone ring structure and not a head-to-tail cyclized backbone. J Am Chem Soc (2003) 1.67
Strategies for the use of mixture-based synthetic combinatorial libraries: scaffold ranking, direct testing in vivo, and enhanced deconvolution by computational methods. J Comb Chem (2007) 1.66
Structure, pharmacology and therapeutic prospects of family C G-protein coupled receptors. Curr Drug Targets (2007) 1.64
Advances in the use of synthetic combinatorial chemistry: mixture-based libraries. Nat Med (2003) 1.43
Chemoinformatic analysis of combinatorial libraries, drugs, natural products, and molecular libraries small molecule repository. J Chem Inf Model (2009) 1.32
Analgesic alpha-conotoxins Vc1.1 and Rg1A inhibit N-type calcium channels in rat sensory neurons via GABAB receptor activation. J Neurosci (2008) 1.29
Shifting from the single to the multitarget paradigm in drug discovery. Drug Discov Today (2013) 1.28
Inhibition of furin by polyarginine-containing peptides: nanomolar inhibition by nona-D-arginine. J Biol Chem (2004) 1.26
Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans. J Exp Med (2002) 1.25
Small-molecule XIAP inhibitors derepress downstream effector caspases and induce apoptosis of acute myeloid leukemia cells. Blood (2005) 1.24
Engineering pro-angiogenic peptides using stable, disulfide-rich cyclic scaffolds. Blood (2011) 1.24
A novel plant protein-disulfide isomerase involved in the oxidative folding of cystine knot defense proteins. J Biol Chem (2007) 1.19
Engineering stabilized vascular endothelial growth factor-A antagonists: synthesis, structural characterization, and bioactivity of grafted analogues of cyclotides. J Med Chem (2008) 1.17
Combinatorial chemistry: libraries from libraries, the art of the diversity-oriented transformation of resin-bound peptides and chiral polyamides to low molecular weight acyclic and heterocyclic compounds. J Org Chem (2004) 1.17
Conserved structural and sequence elements implicated in the processing of gene-encoded circular proteins. J Biol Chem (2004) 1.16
Linearization of a naturally occurring circular protein maintains structure but eliminates hemolytic activity. Biochemistry (2003) 1.14
Expanding the medicinally relevant chemical space with compound libraries. Drug Discov Today (2012) 1.11
Lysine-scanning mutagenesis reveals an amendable face of the cyclotide kalata B1 for the optimization of nematocidal activity. J Biol Chem (2010) 1.09
High-frequency HTR3B variant associated with major depression dramatically augments the signaling of the human 5-HT3AB receptor. Proc Natl Acad Sci U S A (2008) 1.09
A similarity-based data-fusion approach to the visual characterization and comparison of compound databases. Chem Biol Drug Des (2007) 1.09
Solid-phase synthesis of linear ureas tethered to hydantoins and thiohydantoins. J Comb Chem (2002) 1.09
Identification of two novel, potent, low-liability antinociceptive compounds from the direct in vivo screening of a large mixture-based combinatorial library. AAPS J (2010) 1.08
Potential therapeutic applications of the cyclotides and related cystine knot mini-proteins. Expert Opin Investig Drugs (2007) 1.07
Disulfide folding pathways of cystine knot proteins. Tying the knot within the circular backbone of the cyclotides. J Biol Chem (2002) 1.06
Selective agonists and antagonists of formylpeptide receptors: duplex flow cytometry and mixture-based positional scanning libraries. Mol Pharmacol (2013) 1.03
Characterization of activity landscapes using 2D and 3D similarity methods: consensus activity cliffs. J Chem Inf Model (2009) 1.02
Discovery of novel inhibitors of a disintegrin and metalloprotease 17 (ADAM17) using glycosylated and non-glycosylated substrates. J Biol Chem (2012) 1.02
A comparative study of flavonoid analogues on streptozotocin-nicotinamide induced diabetic rats: quercetin as a potential antidiabetic agent acting via 11beta-hydroxysteroid dehydrogenase type 1 inhibition. Eur J Med Chem (2010) 1.01
A traceless approach for the solid-phase parallel synthesis of trisubstituted oxindoles. J Comb Chem (2007) 1.01
HTS by NMR of combinatorial libraries: a fragment-based approach to ligand discovery. Chem Biol (2013) 1.00
Novel D-amino acid tetrapeptides produce potent antinociception by selectively acting at peripheral kappa-opioid receptors. Eur J Pharmacol (2008) 1.00
Excitatory amino acid transporters as potential drug targets. Expert Opin Ther Targets (2009) 1.00
No evidence for a bone phenotype in GPRC6A knockout mice under normal physiological conditions. J Mol Endocrinol (2008) 0.99
Nanaomycin A selectively inhibits DNMT3B and reactivates silenced tumor suppressor genes in human cancer cells. Mol Cancer Ther (2010) 0.99
Changes in Mg2+ ion concentration and heavy chain phosphorylation regulate the motor activity of a class I myosin. J Biol Chem (2004) 0.99
The cyclotide fingerprint in oldenlandia affinis: elucidation of chemically modified, linear and novel macrocyclic peptides. Chembiochem (2007) 0.99
Novel and selective DNA methyltransferase inhibitors: Docking-based virtual screening and experimental evaluation. Bioorg Med Chem (2009) 0.96
Isolation, sequencing, and structure-activity relationships of cyclotides. J Nat Prod (2010) 0.94
Scanning mutagenesis of alpha-conotoxin Vc1.1 reveals residues crucial for activity at the alpha9alpha10 nicotinic acetylcholine receptor. J Biol Chem (2009) 0.94
Kalata B8, a novel antiviral circular protein, exhibits conformational flexibility in the cystine knot motif. Biochem J (2006) 0.94
Exploring polypharmacology using a ROCS-based target fishing approach. J Chem Inf Model (2012) 0.93
The absolute structural requirement for a proline in the P3'-position of Bowman-Birk protease inhibitors is surmounted in the minimized SFTI-1 scaffold. J Biol Chem (2006) 0.93
Use and implications of the harmonic mean model on mixtures for basic research and drug discovery. ACS Comb Sci (2011) 0.93
Molecular modeling and molecular dynamics studies of hydralazine with human DNA methyltransferase 1. ChemMedChem (2009) 0.92
Naturally occurring variations in the human 5-HT3A gene profoundly impact 5-HT3 receptor function and expression. Pharmacogenet Genomics (2007) 0.90
Design, synthesis, and characterization of a single-chain peptide antagonist for the relaxin-3 receptor RXFP3. J Am Chem Soc (2011) 0.90
Short polybasic peptide sequences are potent inhibitors of PC5/6 and PC7: Use of positional scanning-synthetic peptide combinatorial libraries as a tool for the optimization of inhibitory sequences. Mol Pharmacol (2006) 0.90
Modeling of peptides containing D-amino acids: implications on cyclization. J Comput Aided Mol Des (2009) 0.89
Inhibition of neuronal nicotinic acetylcholine receptor subtypes by alpha-Conotoxin GID and analogues. J Biol Chem (2008) 0.89
Multitarget structure-activity relationships characterized by activity-difference maps and consensus similarity measure. J Chem Inf Model (2011) 0.89
Ultra-stable peptide scaffolds for protein engineering-synthesis and folding of the circular cystine knotted cyclotide cycloviolacin O2. Chembiochem (2008) 0.89
Evaluation of toxicity and antitumor activity of cycloviolacin O2 in mice. Biopolymers (2010) 0.88
Design, synthesis, and biological evaluation of Erythrina alkaloid analogues as neuronal nicotinic acetylcholine receptor antagonists. J Med Chem (2013) 0.88
Determination of isokinetic ratios necessary for equimolar incorporation of carboxylic acids in the solid-phase synthesis of mixture-based combinatorial libraries. Biopolymers (2002) 0.88
The Multi-Leu peptide inhibitor discriminates between PACE4 and furin and exhibits antiproliferative effects on prostate cancer cells. J Med Chem (2012) 0.88
Engineering of conotoxins for the treatment of pain. Curr Pharm Des (2011) 0.88
Towards a systematic characterization of the antiprotozoal activity landscape of benzimidazole derivatives. Bioorg Med Chem (2010) 0.88
A novel method for the determination of isokinetic ratios and its application in the synthesis of two new positional scanning libraries. ACS Comb Sci (2012) 0.88
Combinatorial peptide library-based identification of peptide ligands for tumor-reactive cytolytic T lymphocytes of unknown specificity. Eur J Immunol (2002) 0.88
Rational design of alpha-conotoxin analogues targeting alpha7 nicotinic acetylcholine receptors: improved antagonistic activity by incorporation of proline derivatives. J Biol Chem (2009) 0.87
Rapid scanning structure-activity relationships in combinatorial data sets: identification of activity switches. J Chem Inf Model (2013) 0.87
The pharmacological properties of a novel MCH1 receptor antagonist isolated from combinatorial libraries. Eur J Pharmacol (2008) 0.87
Chemical re-engineering of chlorotoxin improves bioconjugation properties for tumor imaging and targeted therapy. J Med Chem (2011) 0.87
Halogenoalkyl isocyanates as bifunctional reagents in an Aza-Wittig/heterocyclization reaction on the solid phase: efficient entry into new tetracyclic benzimidazole systems. J Comb Chem (2004) 0.86
Evaluation of genetic fidelity among micropropagated plants of Gloriosa superba L. using DNA-based markers--a potential medicinal plant. Fitoterapia (2013) 0.86
Parallel synthesis of chiral pentaamines and pyrrolidine containing bis-heterocyclic libraries. Multiple scaffolds with multiple building blocks: a double diversity for the identification of new antitubercular compounds. Bioorg Med Chem Lett (2009) 0.86
Conformation-opioid activity relationships of bicyclic guanidines from 3D similarity analysis. Bioorg Med Chem (2008) 0.86
Synthetic small-molecule prohormone convertase 2 inhibitors. Mol Pharmacol (2008) 0.86
Scaffold ranking and positional scanning utilized in the discovery of nAChR-selective compounds suitable for optimization studies. J Med Chem (2013) 0.86
Interlocking disulfides in circular proteins: toward efficient oxidative folding of cyclotides. Antioxid Redox Signal (2010) 0.86
Identifying key amino acid residues that affect α-conotoxin AuIB inhibition of α3β4 nicotinic acetylcholine receptors. J Biol Chem (2013) 0.85
The mathematics of a successful deconvolution: a quantitative assessment of mixture-based combinatorial libraries screened against two formylpeptide receptors. Molecules (2013) 0.85
Integrating virtual screening and combinatorial chemistry for accelerated drug discovery. Comb Chem High Throughput Screen (2011) 0.85
Discovery of a novel allosteric modulator of 5-HT3 receptors: inhibition and potentiation of Cys-loop receptor signaling through a conserved transmembrane intersubunit site. J Biol Chem (2012) 0.85
High throughput synthesis of peptide alpha-thioesters through the use of "volatilizable" support. J Comb Chem (2008) 0.85
Cloning and characterization of a functional human gamma-aminobutyric acid (GABA) transporter, human GAT-2. J Biol Chem (2007) 0.85
The dance of the clams: twists and turns in the family C GPCR homodimer. Trends Pharmacol Sci (2002) 0.85
Activity of ADAM17 (a disintegrin and metalloprotease 17) is regulated by its noncatalytic domains and secondary structure of its substrates. J Biol Chem (2013) 0.84
Effects of cyclization on stability, structure, and activity of α-conotoxin RgIA at the α9α10 nicotinic acetylcholine receptor and GABA(B) receptor. J Med Chem (2011) 0.84
Structure and activity of alpha-conotoxin PeIA at nicotinic acetylcholine receptor subtypes and GABA(B) receptor-coupled N-type calcium channels. J Biol Chem (2011) 0.84
The alpine violet, Viola biflora, is a rich source of cyclotides with potent cytotoxicity. Phytochemistry (2008) 0.84
Site-specific incorporation of unnatural amino acids into proteins. Chembiochem (2004) 0.83
From rapid in vitro screening to rapid in vivo screening in the drug discovery process. Neuropsychopharmacology (2009) 0.83
Disulfide bond mutagenesis and the structure and function of the head-to-tail macrocyclic trypsin inhibitor SFTI-1. Biochemistry (2005) 0.83
Sunflower trypsin inhibitor-1, proteolytic studies on a trypsin inhibitor peptide and its analogs. Biopolymers (2010) 0.83
Structure of alpha-conotoxin BuIA: influences of disulfide connectivity on structural dynamics. BMC Struct Biol (2007) 0.82
Ginkgolides and glycine receptors: a structure-activity relationship study. Chemistry (2004) 0.82
Improved, high yield synthesis of 3H-quinazolin-4-ones, the key intermediates of recently developed drugs. Curr Med Chem (2004) 0.82
Synthesis of cyclic peptides through direct aminolysis of peptide thioesters catalyzed by imidazole in aqueous organic solutions. J Comb Chem (2009) 0.82